We are live on ! Find out more
ACM

Athyrium Capital Management Portfolio holdings

AUM $8.69M
1-Year Est. Return 34.58%
This Fund
S&P 500
This Quarter Est. Return
-23.96%
1 Year Est. Return
-34.58%
3 Year Est. Return
-25.1%
5 Year Est. Return
10 Year Est. Return
AUM
$208M
AUM Growth
Cap. Flow
+$218M
Cap. Flow %
104.84%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOR
1
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$144M 69.16%
+108,127
New +$159M
AMYT
2
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$64M 30.84%
+4,520,000
New +$59M

Similar funds

Athyrium Capital Management's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Athyrium Capital Management, which disclosed 2 positions worth $208M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Biora Therapeutics, Inc. Common Stock: 108,127 shares worth $144M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Athyrium Capital Management's largest Q4 2020 buy was Biora Therapeutics, Inc. Common Stock: 108,127 shares worth $144M.
  • Athyrium Capital Management's ten largest holdings make up 100% of its $208M portfolio in Q4 2020.
  • Athyrium Capital Management disclosed 2 positions in Q4 2020, its first 13F filing on record.

Based on Athyrium Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.